Multihormonal carcinoid tumor of the pancreas. Secreting growth hormone-releasing factor as a cause of acromegaly

Open Access
Publisher Website
Google Scholar
Abstract
This report describes the histologic, immunocytochemical, and ultrastructural study of a multihormonal carcinoid tumor of the pancreas, secreting a growth hormone releasing factor (GRF) which provoked acromegaly. The patient presented a nonfamilial multiple endocrine neoplasia, type 1. The absence of radiologic signs of a pituitary adenoma in conjunction with elevated plasma levels of pancreatic polypeptide, glucagon, somatostatin, as well as growth hormone (GH), led to the discovery of the tumor. Its surgical excision produced a rapid disappearance of most of the clinical and biologic disorders. No immunoreactive GH was found in the tumor using radioimmunoassay and immunocyto‐chemistry. In contrast, three peptides with GH‐releasing activity were extracted and characterized. Immunocytochemistry showed that the GRF‐reactive cells, together with rare somatostatin‐storing cells, made up areas which demonstrated a medullary pattern of growth with extracellular amyloid deposits. Under electron microscopic examination, actively secreting cells were observed which carried endocrine granules of 100 to 150 nm in diameter. The other regions of the tumor presented a different type of growth and were composed of pancreatic polypeptide‐, glucagon‐, or somatostatin‐reacting cells. Cells immunostained with antisera raised against β‐endorphin were also noted. These data suggest that GRF may be a new biologic marker for pancreatic endocrine tumors.